Artykuły w czasopismach na temat „Broadly neutralizing antibodies (bNAbs)”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Broadly neutralizing antibodies (bNAbs)”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Karuna, Shelly T., i Lawrence Corey. "Broadly Neutralizing Antibodies for HIV Prevention". Annual Review of Medicine 71, nr 1 (27.01.2020): 329–46. http://dx.doi.org/10.1146/annurev-med-110118-045506.
Pełny tekst źródłaYang, Guang, Mengfei Liu, Kevin Wiehe, Nathan Nicely, Barton Haynes, John Mascola, Pamela Bjorkman i Garnett Kelsoe. "HIV broadly neutralizing antibodies and immunological tolerance (VAC7P.988)". Journal of Immunology 192, nr 1_Supplement (1.05.2014): 141.33. http://dx.doi.org/10.4049/jimmunol.192.supp.141.33.
Pełny tekst źródłaLubow, Jay, Lisa M. Levoir, Duncan K. Ralph, Laura Belmont, Maya Contreras, Catiana H. Cartwright-Acar, Caroline Kikawa i in. "Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses". PLOS Pathogens 19, nr 10 (9.10.2023): e1011722. http://dx.doi.org/10.1371/journal.ppat.1011722.
Pełny tekst źródłaSprenger, Kayla G., Joy E. Louveau, Pranav M. Murugan i Arup K. Chakraborty. "Optimizing immunization protocols to elicit broadly neutralizing antibodies". Proceedings of the National Academy of Sciences 117, nr 33 (3.08.2020): 20077–87. http://dx.doi.org/10.1073/pnas.1919329117.
Pełny tekst źródłaGlazkova, D. V., E. V. Bogoslovskaya, G. A. Shipulin i S. M. Yudin. "Broadly neutralizing antibodies for the treatment of HIV infection". HIV Infection and Immunosuppressive Disorders 13, nr 3 (24.10.2021): 81–95. http://dx.doi.org/10.22328/2077-9828-2021-13-3-81-95.
Pełny tekst źródłaShrader, Hannah, Sabrina Helmold Hait, Sarah Lovelace, Meaghan Kilner, Chen-Hsiang Shen, Emily Coates, Martin Gaudinski i in. "Phenotypic analysis of HIV-1 resistance to CD4 binding site broadly-neutralizing antibodies". Journal of Immunology 210, nr 1_Supplement (1.05.2023): 223.08. http://dx.doi.org/10.4049/jimmunol.210.supp.223.08.
Pełny tekst źródłaSteichen, Jon M., Ying-Cing Lin, Colin Havenar-Daughton, Simone Pecetta, Gabriel Ozorowski, Jordan R. Willis, Laura Toy i in. "A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses". Science 366, nr 6470 (31.10.2019): eaax4380. http://dx.doi.org/10.1126/science.aax4380.
Pełny tekst źródłaThavarajah, Jannifer Jasmin, Bo Langhoff Hønge i Christian Morberg Wejse. "The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention". Viruses 16, nr 6 (4.06.2024): 911. http://dx.doi.org/10.3390/v16060911.
Pełny tekst źródłaKumar, Rajesh, Huma Qureshi, Suprit Deshpande i Jayanta Bhattacharya. "Broadly neutralizing antibodies in HIV-1 treatment and prevention". Therapeutic Advances in Vaccines and Immunotherapy 6, nr 4 (sierpień 2018): 61–68. http://dx.doi.org/10.1177/2515135518800689.
Pełny tekst źródłaXu, Ling, Amarendra Pegu, Ercole Rao, Nicole Doria-Rose, Jochen Beninga, Krisha McKee, Dana M. Lord i in. "Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques". Science 358, nr 6359 (20.09.2017): 85–90. http://dx.doi.org/10.1126/science.aan8630.
Pełny tekst źródłaMayer, Bryan T., Allan C. deCamp, Yunda Huang, Joshua T. Schiffer, Raphael Gottardo, Peter B. Gilbert i Daniel B. Reeves. "Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention". PLOS Computational Biology 18, nr 4 (6.04.2022): e1010003. http://dx.doi.org/10.1371/journal.pcbi.1010003.
Pełny tekst źródłaKhurana, Surender, Megan Hahn, Laura Klenow i Hana Golding. "Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins". Viruses 12, nr 10 (8.10.2020): 1140. http://dx.doi.org/10.3390/v12101140.
Pełny tekst źródłaSmith, S. Abigail, i Cynthia A. Derdeyn. "Harnessing the protective potential of HIV-1 neutralizing antibodies". F1000Research 5 (5.01.2016): 20. http://dx.doi.org/10.12688/f1000research.7254.1.
Pełny tekst źródłaMishra, Nitesh, Sanjeev Kumar, Swarandeep Singh, Tanu Bansal, Nishkarsh Jain, Sumedha Saluja, Rajesh Kumar i in. "Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma". PLOS Pathogens 17, nr 9 (24.09.2021): e1009958. http://dx.doi.org/10.1371/journal.ppat.1009958.
Pełny tekst źródłaMcGuire, Andrew T., Sam Hoot, Anita M. Dreyer, Adriana Lippy, Andrew Stuart, Kristen W. Cohen, Joseph Jardine i in. "Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies". Journal of Experimental Medicine 210, nr 4 (25.03.2013): 655–63. http://dx.doi.org/10.1084/jem.20122824.
Pełny tekst źródłaMedina-Ramírez, Max, Fernando Garces, Amelia Escolano, Patrick Skog, Steven W. de Taeye, Ivan Del Moral-Sanchez, Andrew T. McGuire i in. "Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo". Journal of Experimental Medicine 214, nr 9 (28.08.2017): 2573–90. http://dx.doi.org/10.1084/jem.20161160.
Pełny tekst źródłaAn, Zhiyin, Yu Zhang, Xiang Yu, Jia Xia, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan i Yingjie Xu. "The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice". Pharmaceutics 15, nr 5 (5.05.2023): 1412. http://dx.doi.org/10.3390/pharmaceutics15051412.
Pełny tekst źródłaNoailly, Blandine, Melyssa Yaugel-Novoa, Justine Werquin, Fabienne Jospin, Daniel Drocourt, Thomas Bourlet, Nicolas Rochereau i Stéphane Paul. "Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent". Vaccines 10, nr 6 (6.06.2022): 903. http://dx.doi.org/10.3390/vaccines10060903.
Pełny tekst źródłaCaillat, Christophe, Delphine Guilligay, Guidenn Sulbaran i Winfried Weissenhorn. "Neutralizing Antibodies Targeting HIV-1 gp41". Viruses 12, nr 11 (23.10.2020): 1210. http://dx.doi.org/10.3390/v12111210.
Pełny tekst źródłaSakoi-Mosetlhi, Maureen, Gbolahan Ajibola, Roxanna Haghighat, Oganne Batlang, Kenneth Maswabi, Molly Pretorius-Holme, Kathleen M. Powis i in. "Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART". PLOS ONE 19, nr 3 (27.03.2024): e0299942. http://dx.doi.org/10.1371/journal.pone.0299942.
Pełny tekst źródłaWasilewski, Lisa N., Ramy El-Diwany, Supriya Munshaw, Anna E. Snider, Jillian K. Brady, William O. Osburn, Stuart C. Ray i Justin R. Bailey. "A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies". Journal of Virology 90, nr 7 (27.01.2016): 3773–82. http://dx.doi.org/10.1128/jvi.02837-15.
Pełny tekst źródłaStephenson, Kathryn E., Kshitij Wagh, Bette Korber i Dan H. Barouch. "Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention". Annual Review of Immunology 38, nr 1 (26.04.2020): 673–703. http://dx.doi.org/10.1146/annurev-immunol-080219-023629.
Pełny tekst źródłaAli, Ayub, Scott G. Kitchen, Irvin S. Y. Chen, Hwee L. Ng, Jerome A. Zack i Otto O. Yang. "HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies". Journal of Virology 90, nr 15 (25.05.2016): 6999–7006. http://dx.doi.org/10.1128/jvi.00805-16.
Pełny tekst źródłaWelles, Hugh C., Hannah A. D. King, Leonard Nettey, Nicole Cavett, Jason Gorman, Tongqing Zhou, Yaroslav Tsybovsky i in. "Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4". PLOS Pathogens 18, nr 6 (16.06.2022): e1010574. http://dx.doi.org/10.1371/journal.ppat.1010574.
Pełny tekst źródłaBrinkkemper, Mitch, i Kwinten Sliepen. "Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies". Vaccines 7, nr 3 (29.07.2019): 76. http://dx.doi.org/10.3390/vaccines7030076.
Pełny tekst źródłaKlein, Florian, Lilian Nogueira, Yoshiaki Nishimura, Ganesh Phad, Anthony P. West, Ariel Halper-Stromberg, Joshua A. Horwitz i in. "Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants". Journal of Experimental Medicine 211, nr 12 (10.11.2014): 2361–72. http://dx.doi.org/10.1084/jem.20141050.
Pełny tekst źródłaLingwood, Daniel. "Natural gene-encoded affinity for cognate antigen facilitates vaccine-amplification of broadly neutralizing antibodies against influenza virus". Journal of Immunology 202, nr 1_Supplement (1.05.2019): 139.22. http://dx.doi.org/10.4049/jimmunol.202.supp.139.22.
Pełny tekst źródłaDoores, Katie J., Leopold Kong, Stefanie A. Krumm, Khoa M. Le, Devin Sok, Uri Laserson, Fernando Garces, Pascal Poignard, Ian A. Wilson i Dennis R. Burton. "Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope". Journal of Virology 89, nr 2 (5.11.2014): 1105–18. http://dx.doi.org/10.1128/jvi.02905-14.
Pełny tekst źródłaShcherbakov, D. N., A. Yu Bakulina, L. I. Karpenko i A. A. Ilyichev. "Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response". Acta Naturae 7, nr 4 (15.12.2015): 11–21. http://dx.doi.org/10.32607/20758251-2015-7-4-11-21.
Pełny tekst źródłaBiswas, Mrityunjoy, Tatsuya Yamazaki, Joe Chiba i Sachiko Akashi-Takamura. "Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination". Vaccines 8, nr 3 (29.07.2020): 424. http://dx.doi.org/10.3390/vaccines8030424.
Pełny tekst źródłaWang, Qian, i Linqi Zhang. "Broadly neutralizing antibodies and vaccine design against HIV-1 infection". Frontiers of Medicine 14, nr 1 (19.12.2019): 30–42. http://dx.doi.org/10.1007/s11684-019-0721-9.
Pełny tekst źródłaDoria-Rose, Nicole A., Jinal N. Bhiman, Ryan S. Roark, Chaim A. Schramm, Jason Gorman, Gwo-Yu Chuang, Marie Pancera i in. "New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency". Journal of Virology 90, nr 1 (14.10.2015): 76–91. http://dx.doi.org/10.1128/jvi.01791-15.
Pełny tekst źródłavan Dongen, Maria J. P., Rameshwar U. Kadam, Jarek Juraszek, Edward Lawson, Boerries Brandenburg, Frederike Schmitz, Wim B. G. Schepens i in. "A small-molecule fusion inhibitor of influenza virus is orally active in mice". Science 363, nr 6431 (7.03.2019): eaar6221. http://dx.doi.org/10.1126/science.aar6221.
Pełny tekst źródłaMalbec, Marine, Françoise Porrot, Rejane Rua, Joshua Horwitz, Florian Klein, Ari Halper-Stromberg, Johannes F. Scheid i in. "Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission". Journal of Experimental Medicine 210, nr 13 (25.11.2013): 2813–21. http://dx.doi.org/10.1084/jem.20131244.
Pełny tekst źródłaTian, Ming, Kelly McGovern, Hwei-Ling Cheng, Peyton Waddicor, Lisa Rieble, Mai Dao, Yiwei Chen i in. "Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models". Proceedings of the National Academy of Sciences 117, nr 14 (24.03.2020): 7929–40. http://dx.doi.org/10.1073/pnas.1921996117.
Pełny tekst źródłaVanderVeen, Laurie A., Lisa Selzer, Brian Moldt, Aiyappa Parvangada, Jiani Li, Jintanat Ananworanich, Trevor A. Crowell i in. "HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection". AIDS 38, nr 4 (16.11.2023): 607–10. http://dx.doi.org/10.1097/qad.0000000000003792.
Pełny tekst źródłaLiu, Mengfei, Guang Yang, Kevin Wiehe, Nathan I. Nicely, Nathan A. Vandergrift, Wes Rountree, Mattia Bonsignori i in. "Polyreactivity and Autoreactivity among HIV-1 Antibodies". Journal of Virology 89, nr 1 (29.10.2014): 784–98. http://dx.doi.org/10.1128/jvi.02378-14.
Pełny tekst źródłaDiLillo, David, Gene Tan, Peter Palese i Jeffrey Ravetch. "Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo (VAC6P.951)". Journal of Immunology 192, nr 1_Supplement (1.05.2014): 140.12. http://dx.doi.org/10.4049/jimmunol.192.supp.140.12.
Pełny tekst źródłaMkhize, Nonhlanhla N., Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume, David Matten i in. "Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials". PLOS Pathogens 19, nr 6 (29.06.2023): e1011469. http://dx.doi.org/10.1371/journal.ppat.1011469.
Pełny tekst źródłaSwann, Rachael E., Vanessa M. Cowton, Mark W. Robinson, Sarah J. Cole, Stephen T. Barclay, Peter R. Mills, Emma C. Thomson, John McLauchlan i Arvind H. Patel. "Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection". Journal of Virology 90, nr 9 (24.02.2016): 4530–43. http://dx.doi.org/10.1128/jvi.02669-15.
Pełny tekst źródłaMankowski, Madeleine C., Valerie J. Kinchen, Lisa N. Wasilewski, Andrew I. Flyak, Stuart C. Ray, James E. Crowe i Justin R. Bailey. "Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms". Proceedings of the National Academy of Sciences 115, nr 1 (18.12.2017): E82—E91. http://dx.doi.org/10.1073/pnas.1718441115.
Pełny tekst źródłaWalsh, Stephen R., i Michael S. Seaman. "Broadly Neutralizing Antibodies for HIV-1 Prevention". Frontiers in Immunology 12 (20.07.2021). http://dx.doi.org/10.3389/fimmu.2021.712122.
Pełny tekst źródłaLorenzi, Julio C. C., Pilar Mendoza, Yehuda Z. Cohen, Lilian Nogueira, Christy Lavine, Joseph Sapiente, Marie Wiatr i in. "Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates". Journal of Virology, 9.12.2020. http://dx.doi.org/10.1128/jvi.01909-20.
Pełny tekst źródłaAnthony, Colin, Talita York, Valerie Bekker, David Matten, Philippe Selhorst, Roux-Cil Ferreria, Nigel J. Garrett i in. "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope". Journal of Virology 91, nr 18 (5.07.2017). http://dx.doi.org/10.1128/jvi.00828-17.
Pełny tekst źródłaWaters, Laura, Rosa de Miguel-Buckley, Sébastien Poulin i Jose R. Arribas. "Broadly Neutralizing Antibodies for HIV Treatment: Broad in Theory, Narrow in Reality". Clinical Infectious Diseases, 28.10.2022. http://dx.doi.org/10.1093/cid/ciac835.
Pełny tekst źródłaLeggat, David J., Kristen W. Cohen, Jordan R. Willis, William J. Fulp, Allan C. deCamp, Oleksandr Kalyuzhniy, Christopher A. Cottrell i in. "Vaccination induces HIV broadly neutralizing antibody precursors in humans". Science 378, nr 6623 (2.12.2022). http://dx.doi.org/10.1126/science.add6502.
Pełny tekst źródłaSchiffner, Torben, Ivy Phung, Rashmi Ray, Adriana Irimia, Ming Tian, Olivia Swanson, Jeong Hyun Lee i in. "Vaccination induces broadly neutralizing antibody precursors to HIV gp41". Nature Immunology, 30.05.2024. http://dx.doi.org/10.1038/s41590-024-01833-w.
Pełny tekst źródłaSpencer, David A., Mariya B. Shapiro, Nancy L. Haigwood i Ann J. Hessell. "Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic". Frontiers in Public Health 9 (26.05.2021). http://dx.doi.org/10.3389/fpubh.2021.690017.
Pełny tekst źródłaHsu, Denise C., John W. Mellors i Sandhya Vasan. "Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?" Frontiers in Immunology 12 (12.07.2021). http://dx.doi.org/10.3389/fimmu.2021.710044.
Pełny tekst źródłaHuang, Deli, Jenny Tuyet Tran, Alex Olson, Thomas Vollbrecht, Mary Tenuta, Mariia V. Guryleva, Roberta P. Fuller i in. "Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells". Nature Communications 11, nr 1 (17.11.2020). http://dx.doi.org/10.1038/s41467-020-19650-8.
Pełny tekst źródła